In fact, a targeted metabolomic profiling among CKD patients subjected to hyperinsulinemic-euglycemic insulin clamp revealed that CKD was associated with disruption in amino acid metabolism and mitochondrial function that impaired anabolic effects on insulin contributing to PEW and muscle atrophy [35]. This evidence concerns the gene INS and chronic kidney disease.